Home
This site is intended for healthcare professionals
Advertisement

The World of Paediatrics: Diabetes & Endocrinology

Share
Advertisement
Advertisement
 
 
 

Summary

Join Dr. Kathryn Cox in the upcoming session on Paediatric Endocrinology & Diabetes in November 2023. The comprehensive program covers a broad variety of topics, offering insights into areas like common conditions of pediatric diabetes and endocrine, fascinating cases, contemporary research, and developing areas in the field. Apart from providing theoretical knowledge, this session also offers a glimpse into practical aspects such as the day-to-day life of a pediatric diabetes and endocrine consultant. Beyond the clinic, the session addresses Dr. Cox's passion for supporting children and young people, fostering equality, promoting life opportunities, and improving workplace wellbeing. This session will suit medical professionals seeking a thorough understanding of Pediatric Endocrinology and Diabetes or considering a specialization in the field.

Generated by MedBot

Description

🧸 Welcome to the second talk of our 'The World of Paediatrics: Subspecialty Series' on Diabetes & Endocrinology. 🧸

This talk will be delivered by Dr Kathryn Cox, a Consultant Paediatrician in Endocrinology and Diabetes at the Royal Hospital for Children & Young People in Edinburgh.

đź“Ł This talk will cover all things related to Paediatric Diabetes & Endocrinology, which is a key aspect of being a Paediatrician!

đź“… Date: 29th November (Wednesday)

đź•• Time: 6 pm

đź“Ť Venue: Online (MedAll)

Don't miss out on this opportunity! See you all there!

Learning objectives

  1. Understand and explain the role and responsibilities of a pediatric endocrine and diabetes consultant.
  2. Identify and explain common conditions in pediatric endocrinology and diabetes, and present cases with these conditions.
  3. Discuss and provide insights on the latest research and developments in pediatric endocrinology and diabetes.
  4. Describe the care and management protocols for patients with conditions such as type 1 diabetes, hypothyroidism, and short stature.
  5. Analyze the importance of multidisciplinary approach, patient-centered care, and continuous learning in the field of pediatric endocrinology and diabetes.
Generated by MedBot

Similar communities

View all

Similar events and on demand videos

Computer generated transcript

Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.

Paediatric Endocrinology & Diabetes EUPS November 2023 Dr Kathryn CoxOutline • Why Endocrinology and Diabetes • Life as a paediatric diabetes and endocrine consultant • Common conditions • Interesting cases • Developing areas and current research • SummaryWhy endocrinology and diabetes? • Growth and development: the key things that differentiate children from adults! • Huge variety of patients and conditions • Lifelong relationships with patients and families • Opportunity to maximise health and potential • Teamwork • Always learning(Why not?) • Not very many emergencies • No procedures • You don’t spend much time in the hospital overnight • Not for you if you don’t like communicatingMy passions • Supporting children and young people of all ages • Equality and improving life opportunities • Wellbeing at work • KindnessTypical Day? – No such thing! Outpatient diabetes & endocrine D&E Hot weeks Acute general paediatricsOutpatient Weeks • Regular, annual review and new patient diabetes clinics • Young person’s clinic • General endocrine clinics for new and review patients • Specialist and outreach endo clinics • Multi-disciplinary meetings • Planning and chasing up investigations • Service planning and development • …. EmailsHot Weeks • Daily ward rounds (attention to detail) • See and assess urgent referrals • Triage routine referrals • Attend ED for new patients • Advice to outreach centres • Teaching • …EmailsAcute Paediatrics • Daily ward round • Supporting trainees • Phone advice to primary care • …Fewer emails!What does a paediatric endocrinologist see? Hypo/ Hyper Type 1 Diabetes Short / Tall thyroid Stature Autoimmune Complications of Excess Early/ Delayed Type 2 Diabetes Genetic & Weight puberty syndromic causes Adrenal Differences of Bone & Calcium insufficiency/ sex disorders excess development Tumours Hyperinsulinism Diabetes Menstrual Insipidus disordersCommon presentations in diabetes and endocrinologyType 1 Diabetes Mellitus • 4 year old boy attends GP with bedwetting and tiredness • No dysuria • Toilet trained aged 2y, recently started having some “accidents” • Episode of thrush two weeks ago • Mum thinks his clothes look looserGP suspects diabetes – what test? a. Lab glucose b. Lab HbA1c c. Urine dip for glucose d. Fingerprick glucose e. Oral Glucose tolerance testGP suspects diabetes – what test? a. Lab glucose b. Lab HbA1c c. Urine dip for glucose d. Fingerprick glucose e. Oral Glucose tolerance testFingerprick glucose is 12.3mmol/l What should the GP do next? a. Ask family to attend paediatric ED department b. Give 5 units of subcutaneous novorapid insulin c. Write an urgent referral letter to paediatric diabetes d. Arrange a glucose tolerance test e. Re-check blood glucose in the practice the same dayFingerprick glucose is 12.3mmol/l What should the GP do next? a. Ask family to attend paediatric ED department b. Give 5 units of subcutaneous novorapid insulin c. Write an urgent referral letter to paediatric diabetes d. Arrange a glucose tolerance test e. Re-check blood glucose in the practice the same dayThe family bring the child to ED The family give a history consistent with diabetes. The child looks well, is chatting and has a PEWS of 0. What tests should be done? a. Type 1 diabetes genetic risk score, U&Es, blood ketones, blood gas, TFTs, glucose b. Diabetes autoantibodies, U&Es, blood ketones, blood gas, TFTs, glucose c. Diabetes autoantibodies, Type 1 diabetes genetic risk score, U&Es, blood gas, TFTs, glucose d. U&Es, blood ketones, blood gas, TFTs, glucose, Thyroid receptor antibodies e. Diabetes autoantibodies, U&Es, blood ketones, blood gas, LFTs, glucoseThe family bring the child to ED The family give a history consistent with diabetes. The child looks well, is chatting and has a PEWS of 0. What tests should be done? a. Type 1 diabetes genetic risk score, U&Es, blood ketones, blood gas, TFTs, glucose b. Diabetes autoantibodies, U&Es, blood ketones, blood gas, TFTs, glucose c. Diabetes autoantibodies, Type 1 diabetes genetic risk score, U&Es, blood gas, TFTs, glucose d. U&Es, blood ketones, blood gas, TFTs, glucose, Thyroid receptor antibodies e. Diabetes autoantibodies, U&Es, blood ketones, blood gas, LFTs, glucoseNext Steps • Explanation: he has diabetes, will require lifelong treatment with insulin injections • Admitted to hospital, usually for at least 2 nights • Basal bolus insulin is started with Novorapid and Tresiba • The family and child receive intensive inpatient training: • Finger prick testing • Blood glucose targets and how to manage hypoglycaemia • Insulin injections • Carbohydrate counting • Ongoing education and clinic review • Insulin Pump (Continuous subcutaneous insulin infusion)10 day old baby • Telephone call from newborn screening lab to endocrine consultant • TSH result from day 5 screening is 23mU/l • Upper limit of normal is 8mU/l • Consultant arranges for child to attend paediatric outpatients the same day • Explanation to familyClinical assessment • History: • Poor feeding, sleepiness, jaundice, constipation, cold peripheries, hoarse cry • Affected family members • Thyroid treatment in the mother • Examination: • Measure weight, head circumference and length • Measure parental heights • Presence or absence of goitre • Signs of hypothyroidism (coarse facies, hoarse cry, umbilical hernia, dry skin)Investigation & Management • TSH, free T4 and thyroglobulin levels • Consider thyroid imaging • Provide prescription for Levothyroxine • If no signs and screening TSH <50 then can wait for results • Otherwise start levothyroxine before results are available • Weekly then fortnightly review to ensure adequate treatment • Continue treatment until at least 3 years of age to ensure optimal brain developmentShort Stature • 4 year old girl • Family have noticed she is shorter than friends • Born at term, normal birth weight • No feeding difficulties, eats a vegan diet • Eczema treated with emollients • Viral induced wheezeWhich of these do not suggest short stature or slow growth? a. Height below the 0.4th centile b. Height 2 centiles or more below the mid-parental height c. Height 2 centiles below weight centile d. Height below the 2nd centile with height velocity less than the 25th centile e. Crossing more than 1 height centile in 1 year, after age of 2 yearsWhich of these do not suggest short stature or slow growth? a. Height below the 0.4th centile b. Height 2 centiles or more below the mid-parental height c. Height 2 centiles below weight centile d. Height below the 2nd centile with height velocity less than the 25th centile e. Crossing more than 1 height centile in 1 year, after age of 2 yearsWhat are the most appropriate investigations? a. FBC, coeliac screen, IGF-1, TFTs, bone age X-ray b. FBC, coeliac screen, ESR, IGF-1, bone age X-ray c. FBC, IGF-1, TFTs, coeliac screen, DEXA scan d. FBC, coeliac screen, TFTs, c-peptide, bone age X-ray e. FBC, coeliac screen, TFTs, growth hormone, DEXA scanWhat are the most appropriate investigations? a. FBC, coeliac screen, IGF-1, TFTs, bone age X-ray b. FBC, coeliac screen, ESR, IGF-1, bone age X-ray c. FBC, IGF-1, TFTs, coeliac screen, DEXA scan d. FBC, coeliac screen, TFTs, c-peptide, bone age X-ray e. FBC, coeliac screen, TFTs, growth hormone, DEXA scanResults • Normal FBC, LFT, cortisol, TFTs, coeliac screen • Low IGF-1 • Bone age delay • Bone age 2.81 years.19 years • Needs further investigationInsulin tolerance test • Stimulation test of pituitary function • Measure baseline growth hormone and cortisol • Induce hypoglycaemia using injected insulin RISK OF SEIZURES AND DEATH • Frequent monitoring of blood glucose • Re-check growth hormone & cortisol after 20, 30, 60 and 90 minutesResults • Lowest blood glucose 1.0mmol/l • Peak growth hormone 3.27mcg/l • Peak cortisol 812nmol/l • Interpretation • GH peak below 5mcg/L considered abnormal: this is diagnostic of Growth hormone deficiency • GH peak below 3.3mcg/L is diagnostic of severe Growth hormone deficiency • Hypoglycaemia should induce Cortisol peak above 400nmol/lResults • Lowest blood glucose 1.0mmol/l • Peak growth hormone 3.27mcg/l • Peak cortisol 812nmol/l • Interpretation • GH peak below 5mcg/L considered abnormal: this is diagnostic of Growth hormone deficiency • GH peak below 3.3mcg/L is diagnostic of severe Growth hormone deficiency • Hypoglycaemia should induce Cortisol peak above 400nmol/l • Growth Hormone deficiency with normal cortisol productionNext steps • MRI Pituitary – Normal • Started on growth hormone • Nightly sub cut injection – training for family • 6-monthly review & blood monitoringPossible precocious puberty • 7 year old girl with breast development • Mum noticed breast development over a few months • Not noticed growth spurt • Some acne & greasy skin • Family history: mum & older sister had menarche at 13y • Initial results: LH 0.8, FSH 3.8, Oetradiol 68 • Detectable LH level and oestradiol suggest early pubertyReview after 3 monthsCalculate growth velocity • Measuring growth velocity in Age Height cm/year 7.899 years 122.2 cm • Plot on standardised growth 8.181 years 127.2 cm velocity centile chartCalculate growth velocity • Measuring growth velocity in Age Height cm/year 7.899 years 122.2 cm 8.181 years 127.2 cm • Plot on standardised growth velocity centile chart Growth = 127.2- 122.2 = 5cm Time = 8.181-7.899 = 0.282 years Growth velocity = 17.7cm/yFurther investigation • Gonadotrophin releasing hormone test - stimulation test • Measures baseline and stimulated levels of LH & FSH RESULTS LH FSH Baseline 2.1 3.3 Peak 52.9 17.7Interpretation • Rapid Progression through puberty • Treatment with pubertal blocker • GnRH agonist – Decapeptyl injections • Close monitoring of responseUnusual and intriguing casesCase 1 • 10 year old boy referred with central obesity & moon face • Topical steroid treatment for congenital skin condition • Severe pain, unable to walk, having nightmaresSevere Cushing Syndrome • Moon face with plethora • Central obesity • Skin thinning • Striae • Muscle wastingFeatures • Adrenal insufficiency • Hypertension • Osteoporosis with crush fractures • Fatty liver disease • Immobility and weaknessManagement • Multidisciplinary • GI, Renal, Endocrine, Pain, Orthopaedics, Dermatology, Physiotherapy • Stop steroid cream & give appropriate skin treatment • Replacement hydrocortisone and sick day plan • Weaned off antihypertensives • Repeat synacthen – passed after 1 year • Liver now normalisedRecovery • Off all medication • Pain free • Enjoying school • Riding bike and running • Skin dramatically improved • Rapid growthCase 2 • 13 year old boy with chronic pancreatitis • Autistic spectrum disorder • Pancreatic insufficiency • Recurrent acute pancreatitis • Recurrent episodes of pain and poor oral intake • MDT decision for total pancreatectomyPancreatic function Amylase Insulin Lipase Protease GlucagonAutologous Islet Cell Transplant • Pancreas surgically removed • Pancreas processed and centrifuged to extract islet cells • Islet cells reinfused into portal vein • Cell recovery starts immediately but takes time to reach full insulin production • Exogenous insulin required to maintain normoglycaemia during recovery This image shows Allogeneic islet cell transplantNew developments & researchIslet cell transplant • Currently not suitable for most Type 1 as allogeneic transplant requires immunosuppression • Can be used when patients require transplant for another reason • Renal transplant • Lung transplant in Cystic Fibrosis Diabetes • Future Possibilities: • Islets harvested pre-Type 1 allowing later autologous transplant • Lab-grown insulin producing cellsDiabetes screening and immunotherapy • Type 1 screening for 3-13 year olds • Using Verapamil or Monoclonal • Population screening for 4 diabetes antibodies to preserve beta cell autoantibodies function • Option to use in early diabetes or • Initial test on finger prick pre-diagnosis • 1% of those tested will need venous bloods •insulin delay or prevent use of • 2 or more Ab = very high lifetime risk of diabetes • Teplizumab licensed in USA – • Family education delays onset by 3 yearsDiabetes T echnology • Insulin pumps • Continuous Glucose Monitoring • Hybrid closed loop systemsEndocrine developments • Neonatal screening for Congenital adrenal hyperplasia • Targeted therapies based on genetic diagnosis • Burosomab • Setmelanotide • Hormone stimulation treatment • Pubertal induction with GnRH analogues • PTH pumpsSummary • Endocrinology and diabetes is a rewarding and varied career • Multidisciplinary team working, and opportunities to work with teams from across the hospital • Emerging technology and treatments • There is always something new to learn!Thank you for listening! Any Questions? Thank you to all my patients and colleagues who teach me so much! Please get in touch: kathryn.cox@nhslothian.scot.nhs.uk